Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1961 1
1963 2
1964 3
1967 1
1969 1
1973 1
1988 1
1989 1
1990 1
2001 7
2002 4
2003 5
2004 4
2005 2
2006 8
2007 2
2008 2
2009 5
2010 3
2011 4
2012 3
2013 11
2014 7
2015 11
2016 9
2017 16
2018 11
2019 4
2020 6
2021 6
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Strosberg J, et al. Among authors: wolin e. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. N Engl J Med. 2017. PMID: 28076709 Free PMC article. Clinical Trial.
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP; NETTER-1 investigators. Strosberg JR, et al. Among authors: wolin em. Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15. Lancet Oncol. 2021. PMID: 34793718 Clinical Trial.
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.
Giovanella L, Avram AM, Iakovou I, Kwak J, Lawson SA, Lulaj E, Luster M, Piccardo A, Schmidt M, Tulchinsky M, Verburg FA, Wolin E. Giovanella L, et al. Among authors: wolin e. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2514-2525. doi: 10.1007/s00259-019-04472-8. Epub 2019 Aug 7. Eur J Nucl Med Mol Imaging. 2019. PMID: 31392371
Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Blumberg J, Ruszniewski P; CLARINET Investigators. Caplin ME, et al. Among authors: wolin em. N Engl J Med. 2014 Jul 17;371(3):224-33. doi: 10.1056/NEJMoa1316158. N Engl J Med. 2014. PMID: 25014687 Free article. Clinical Trial.
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.
Yao JC, Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, Pacaud LB, Rouyrre N, Sachs C, Valle JW, Fave GD, Van Cutsem E, Tesselaar M, Shimada Y, Oh DY, Strosberg J, Kulke MH, Pavel ME; RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group. Yao JC, et al. Among authors: wolin e. Lancet. 2016 Mar 5;387(10022):968-977. doi: 10.1016/S0140-6736(15)00817-X. Epub 2015 Dec 17. Lancet. 2016. PMID: 26703889 Free PMC article. Clinical Trial.
Randomized Controlled Trials in Neuroendocrine Tumors.
McAuliffe JC, Wolin EM. McAuliffe JC, et al. Among authors: wolin em. Surg Oncol Clin N Am. 2017 Oct;26(4):751-765. doi: 10.1016/j.soc.2017.05.012. Epub 2017 Aug 4. Surg Oncol Clin N Am. 2017. PMID: 28923229 Review.
Perfusion Imaging in Acute Traumatic Brain Injury.
Douglas DB, Chaudhari R, Zhao JM, Gullo J, Kirkland J, Douglas PK, Wolin E, Walroth J, Wintermark M. Douglas DB, et al. Among authors: wolin e. Neuroimaging Clin N Am. 2018 Feb;28(1):55-65. doi: 10.1016/j.nic.2017.09.002. Epub 2017 Oct 23. Neuroimaging Clin N Am. 2018. PMID: 29157853 Free PMC article. Review.
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors.
Eads JR, Reidy-Lagunes D, Soares HP, Chan JA, Anthony LB, Halfdanarson TR, Naraev BG, Wolin EM, Halperin DM, Li D, Pommier RF, Zacks JS, Morse MA, Metz DC; from the Carcinoid Syndrome Control Collaborative. Eads JR, et al. Among authors: wolin em. Pancreas. 2020 Oct;49(9):1123-1130. doi: 10.1097/MPA.0000000000001658. Pancreas. 2020. PMID: 32991344 Review.
Large-scale map of RNA binding protein interactomes across the mRNA life-cycle.
Street L, Rothamel K, Brannan K, Jin W, Bokor B, Dong K, Rhine K, Madrigal A, Al-Azzam N, Kim JK, Ma Y, Abdou A, Wolin E, Doron-Mandel E, Ahdout J, Mujumdar M, Jovanovic M, Yeo GW. Street L, et al. Among authors: wolin e. bioRxiv [Preprint]. 2023 Jun 8:2023.06.08.544225. doi: 10.1101/2023.06.08.544225. bioRxiv. 2023. PMID: 37333282 Free PMC article. Preprint.
Femoral Neck Fracture with Avascular Necrosis.
Ballas ER, Nguyen VT, Wolin EA. Ballas ER, et al. Among authors: wolin ea. J Nucl Med Technol. 2023 Mar;51(1):78-79. doi: 10.2967/jnmt.122.264354. Epub 2022 Aug 30. J Nucl Med Technol. 2023. PMID: 36041873 Free article.
137 results